← back to search

Emily Moore

University of Technology Sydney · AU
Area of research
Infectious Diseases · Obstetrics and Gynecology
Research interest
Research interests include COVID-19 Impact on Reproduction, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Cardiac, Anesthesia and Surgical Outcomes.
h-index
17
citations
1,716
works
51
NIH funding
primary concept
Medicine
email

Recent publications

A population-based matched cohort study of major congenital anomalies following COVID-19 vaccination and SARS-CoV-2 infection
Nature Communications 2023cited by 39position: middledoi
Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study
Nature Communications 2023cited by 33position: middledoi
Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people
EClinicalMedicine 2022cited by 80position: middledoi
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
The Lancet Respiratory Medicine 2022cited by 77position: middledoi
First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
PLoS Medicine 2022cited by 60position: middledoi
A population-based matched cohort study of early pregnancy outcomes following COVID-19 vaccination and SARS-CoV-2 infection
Nature Communications 2022cited by 40position: middledoi
Investigating the uptake, effectiveness and safety of COVID-19 vaccines: protocol for an observational study using linked UK national data
BMJ Open 2022cited by 11position: middledoi
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
The Lancet 2021cited by 603position: middledoi
First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
Nature Medicine 2021cited by 260position: middledoi
Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People
SSRN Electronic Journal 2021cited by 135position: middledoi
Impact of First UK COVID-19 Lockdown on Hospital Admissions: Interrupted Time Series Study of 32 Million People
SSRN Electronic Journal 2021cited by 2position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Srinivasa Vittal Katikireddi · MRC/CSO Social and Public Health Sciences Unit5 papers (2021–2023)Aziz Sheikh · National Institute of Technology Srinagar5 papers (2021–2023)Colin R Simpson · Victoria University of Wellington5 papers (2021–2023)Lisa Hopcroft · University of Glasgow3 papers (2022–2023)Clara Calvert · Centre for Global Health Research3 papers (2022–2023)Sarah J. Stock · Trinity College Dublin3 papers (2022–2023)Jack Donaghy · Public Health Scotland3 papers (2022–2023)Terry McLaughlin · Public Health Scotland3 papers (2022–2023)Jade Carruthers · Public Health Scotland3 papers (2022–2023)Cheryl Denny · Public Health Scotland3 papers (2022–2023) · 3 papers (2022–2023)Chris Robertson · University of Strathclyde3 papers (2022–2023)Anna Goulding · Public Health Scotland3 papers (2022–2023)Rachael Wood · University of Canterbury3 papers (2022–2023)Leanne Hopkins · Public Health Scotland3 papers (2022–2023)Helen J Curtis · Angkor Hospital for Children2 papers (2021–2022)Ben Goldacre · Angkor Hospital for Children2 papers (2021–2022)Brian MacKenna · Science Oxford2 papers (2021–2022)Roxanne Cooksey · Swansea University2 papers (2021–2022)J. R. Taylor · Public Health Scotland2 papers (2023–2023)